Advertisement

Dietary Retinoids and the Chemoprevention of Mammary Gland Tumorigenesis

  • Clifford W. Welsch
Chapter

Abstract

Over the years, the thrust of cancer therapy has been the destruction of malignant cells; comparatively little effort has been directed toward modifying the behavior of malignant cells toward normalcy. In recent years, considerable interest in the use of dietary retinoids (vitamin A and its naturally occurring and synthetic analogues) as potential mediators of this process has come to the fore. To date, the “chemopreventive” effects of dietary retinoids have been demonstrated in a variety of experimental tumor models; tumorigenesis of the bladder, cervix, colon, forestomach, integument, liver, lung, pancreas, vagina and mammary glands has been suppressed by the feeding of pharmacological levels of natural and synthetic retinoids. The purpose of this communication is to provide a succinct review of the pertinent information that has emerged in recent years documenting the use of retinoids in the chemoprevention of mammary tumorigenesis in experimental animals. More specifically, this review will examine the chemopreventive effects of dietary retinoids in the development of mammary tumors in rats and mice and lastly will focus on potential mechanisms by which these compounds may suppress tumorigenesis.

Keywords

Mammary Gland Mammary Tumor Mammary Carcinoma Mouse Mammary Gland Mammary Carcinogenesis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Moon, R.C., Grubbs, C.J., and Sporn, M.B. Inhibition of 7,12-dimethylbenzanthracene-induced mammary carcinogenesis by retinyl acetate. Cancer Res., 36: 2626 – 2630, 1976.PubMedGoogle Scholar
  2. 2.
    McCormick, D.L., Burns, F.J., and Albert, R.E. Inhibition of rat mammary carcinogenesis by short dietary exposures to retinyl acetate. Cancer Res., 40: 1140 – 1143, 1980.PubMedGoogle Scholar
  3. 3.
    Ip, C., and Ip, M.M. Chemoprevention of mammary tumorigenesis by a combined regimen of selenium and vitamin A. Carcinogenesis, 2: 915 – 918, 1981.PubMedCrossRefGoogle Scholar
  4. 4.
    Thompson, H.J., Meeker, L.D., Tagliaferro, A.R., and Becci, P.J. Effect of retinyl acetate on the occurrence of ovarian hormone responsive and nonresponsive mammary cancers in the rat. Cancer Res., 42: 903 – 905, 1982.PubMedGoogle Scholar
  5. 5.
    Welsch, C.W., and DeHoog, J.V. Retinoid feeding, hormone inhibition, and/or immune stimulation and the genesis of carcinogen-induced rat mammary carcinomas. Cancer Res., 43: 585 – 591, 1983.PubMedGoogle Scholar
  6. 6.
    Grubbs, C.J., Moon, R.C., Sporn, M.B., and Newton, D.L. Inhibition of mammary cancer by retinyl methyl ether. Cancer Res., 37: 599 – 602, 1977.PubMedGoogle Scholar
  7. 7.
    McCormick, D.L., Mehta, R.G., Thompson, C.A., Dinger, N., Caldwell, J.A., and Moon, R.C. Enhanced inhibition of mammary carcinogenesis by combined treatment with N-(4-hydroxyphenyl) retinamide and ovariectomy. Cancer Res., 42: 508 – 512, 1982.PubMedGoogle Scholar
  8. 8.
    Moon, R.C., Grubbs, C.J., Sporn, M.B., and Goodman, D.G. Retinyl acetate inhibits mammary carcinogenesis induced by N-methyl-N-nitrosourea. Nature, 267: 620 – 621, 1977.PubMedCrossRefGoogle Scholar
  9. 9.
    Welsch, C.W., Brown, C.K., Goodrich-Smith, M., Chiusano, J., and Moon, R.C. Synergistic effect of chronic prolactin suppression and retinoid treatment in the prophylaxis of N-methyl-N-nitrosourea-induced mammary tumorigenesis in female Sprague-Dawley rats. Cancer Res., 40: 3095 – 3098, 1980.PubMedGoogle Scholar
  10. 10.
    Thompson, H.J., Meeker, L.D., and Becci, P.J. Effect of combined selenium and retinyl acetate treatment on mammary carcinogenesis. Cancer Res., 41: 1413 – 1416, 1981.PubMedGoogle Scholar
  11. 11.
    McCormick, D.L., Sowell, Z.L., Thompson, C.A., and Moon, R.C. Inhibition by retinoid and ovariectomy of additional primary malignancies in rats following surgical removal of the first mammary cancer. Cancer, 51: 594 – 599, 1983.PubMedCrossRefGoogle Scholar
  12. 12.
    Moon, R.C., and McCormick, D.L. Inhibition of chemical carcinogenesis by retinoids. J. Am. Acad. Dermatol., 6: 809 – 814, 1982.PubMedCrossRefGoogle Scholar
  13. 13.
    Moon, R.C., Thompson, H.J., Becci, P.J., Grubbs, C.J., Gander, R.J., Newton, D.L., Smith, J.M., Phillips, S.L., Henderson, W.R., Mullen L.T., Brown, C.C., and Sporn, M.B. N-(4-hydroxyphenyl) retinamide, a new retinoid for prevention of breast cancer in the rat. Cancer Res., 39: 1339 – 1346, 1979.PubMedGoogle Scholar
  14. 14.
    McCormick, D.L., Burns, F.J., and Albert, R.E. Inhibition of benzopyrene-induced mammary carcinogenesis by retinyl acetate. J. Natl. Cancer Inst., 66: 559 – 564, 1981.PubMedGoogle Scholar
  15. 15.
    Silverman, J., Katayama, S., Radok, P., Levenstein, M.J., and Weisburger, J.H. Effect of short-term administration of N-(4-hydroxyphenyl)-all-trans-retinamide on chemically induced mammary tumors. Nutr. Cancer, 4: 186 – 191, 1983.PubMedCrossRefGoogle Scholar
  16. 16.
    Aylsworth, C.F., Cullum, M.E., Zile, M.H., and Welsch, C.W. Influence of dietary retinyl acetate on normal rat mammary gland development and on the enhancement of 7,12-dimethylbenzanthracene induced rat mammary tumorigenesis by high levels of dietary fat. J. Natl. Cancer Inst., 76: 339 – 345, 1986.PubMedGoogle Scholar
  17. 17.
    Gandilhon, P., Melancon, R., Djiane, J., and Kelly, P.A. Comparison of ovariectomy and retinyl acetate on the growth of established 7,12-dimethylbenzanthracene-induced mammary tumors in the rat. J. Natl. Cancer Inst., 69: 447 – 451, 1982.PubMedGoogle Scholar
  18. 18.
    Welsch, C.W., DeHoog, J.V., Scieszka, K.M., and Aylsworth, C.F. Retinoid feeding, hormone inhibition and/or immune stimulation and the progression of MNU-induced rat mammary carcinoma: suppression by retinoids of peptide hormone induced tumor cell proliferation in vivoand in vitro. Cancer Res., 44: 166 – 171, 1984.PubMedGoogle Scholar
  19. 19.
    McCormick, D.L., Becci, P.J., and Moon, R.C. Inhibition of mammary and urinary bladder carcinogenesis by a retinoid and a maleic anhydride-devinyl ether copolymer (MVE-2). Carcinogenesis, 3: 1473 – 1477, 1982.PubMedCrossRefGoogle Scholar
  20. 20.
    Stone, J.P., Shellabarger, C.J., and Holtzman, S. Retinoid inhibition of radiation-induced chemically-induced and spontaneous rat mammary carcinogenesis: interim results. In:J.J. Broerse, G.W. Barendsen, H.B. Kal and A.J. van der Kogel (eds.), Proc. 7th Internatl. Cong. Rad. Res., Somatic and Genetic Effects, pp. 16–17. Amsterdam: Martinus Nijhoff Pub., 1983.Google Scholar
  21. 21.
    Lotan, R., and Nicolson, G.L. Inhibitory effects of retinoic acid or retinyl acetate on the growth of untransformed, transformed and tumor cells in vitro. J. Natl. Cancer Inst., 59, 1717 – 1722, 1977.PubMedGoogle Scholar
  22. 22.
    Rudland, P.S., Paterson, F.C., Davies, A.C.T., and Warburton, M.J. Retinoid specific induction of differentiation and reduction of the DNA synthesis rate and tumor-forming ability of a stem cell line from a rat mammary tumor. J. Natl. Cancer Inst., 70: 949 – 958, 1983.PubMedGoogle Scholar
  23. 23.
    Maiorana, A., and Gullino, P.M. Effect of retinyl acetate on the incidence of mammary carcinomas and hepatomas in mice. J. Natl. Cancer Inst., 64, 655 – 663, 1980.PubMedGoogle Scholar
  24. 24.
    Welsch, C.W., DeHoog, J.V., and Moon, R.C. Inhibition of mammary tumorigenesis in nulliparous C3H mice by chronic feeding of the synthetic retinoid, N-(4-hydroxyphenyl)-retinamide. Carcinogenesis, 4, 1185 – 1187, 1983.PubMedCrossRefGoogle Scholar
  25. 25.
    Welsch, C.W., Goodrich-Smith, M., Brown, C.K., and Crowe, N. Enhancement by retinyl acetate of hormone-induced mammary tumorigenesis in female GR/A mice. J. Natl. Cancer Inst., 67: 935 – 938, 1981.PubMedGoogle Scholar
  26. 26.
    Welsch, C.W., and DeHoog, J.V. Lack of an effect of dietary retinoids in chemical carcinogenesis of the mouse mammary gland: inverse relationship between mammary tumor cell anaplasia and retinoid effectiveness. Carcinogenesis, 5: 1301 – 1304, 1984.PubMedCrossRefGoogle Scholar
  27. 27.
    Weiss, L., and Holyoke, E.D. Some effects of hypervitaminosis A on metastasis of spontaneous breast cancer in mice. J. Natl. Cancer Inst., 43: 1045 – 1054, 1969.PubMedGoogle Scholar
  28. 28.
    Rettura, G., Schittek, A., Hardy, M., Levenson, S.M., Demetriou, A., and Seifter, E. Antitumor action of vitamin A in mice inoculated with adenocarcinoma cells. J. Natl. Cancer Inst., 54: 1489 – 1491, 1975.PubMedGoogle Scholar
  29. 29.
    Rettura, G., Stratford, F., Levenson, S.M., and Seifter, E. Prophylactic and therapeutic actions of supplemental/3-carotene in mice inoculated with C3HBA adenocarcinoma cells: lack of therapeutic action of supplemental ascorbic acid. J. Natl. Cancer Inst., 69: 73 – 77, 1982.PubMedGoogle Scholar
  30. 30.
    Dickens, M.S., Custer, R.P., and Sorof, S. Retinoid prevents mammary gland transformation by carcinogenic hydrocarbon in whole-organ culture. Proc. Natl. Acad. Sci., U.S.A., 76: 5891 – 5895, 1979.PubMedCrossRefGoogle Scholar
  31. 31.
    Dickens, M.S., and Sorof, S. Retinoid prevents transformation of cultured mammary glands by procarcinogens but not by many activated carcinogens. Nature, 285: 581 – 584, 1980.PubMedCrossRefGoogle Scholar
  32. 32.
    Chatterjee, M., and Banerjee, M.R. N-nitrosodiethylamine-induced nodule-like alveolar lesion and its prevention by a retinoid in BALB/c mouse mammary glands in the whole organ in culture. Carcinogenesis, 3: 801 – 804, 1982.PubMedCrossRefGoogle Scholar
  33. 33.
    Chatterjee, M., and Banerjee, M.R. Influence of hormones on N-(4-hydroxypheny1) retinamide inhibition of 7,12-dimethylbenzan-thracene transformation of mammary cells in organ culture. Cancer Letters, 16: 239 – 245, 1982.PubMedCrossRefGoogle Scholar
  34. 34.
    Som, S., Chatterjee, M., and Banerjee, M.R. beta-carotene inhibition of 7,12-dimethylbenzanthracene-induced transformation of murine mammary cells in vitro. Carcinogenesis, 5: 937 – 940, 1984.PubMedCrossRefGoogle Scholar
  35. 35.
    Teland, N.T., and Sarkar, N.H. Long-term survival of adult mouse mammary glands in culture and their response to a retinoid. Cancer Res., 43: 4891 – 4900, 1983.Google Scholar
  36. 36.
    Rieber, M., and Seyler, L. Growth inhibition of mouse mammary tumor cells by dexamethasone concurrent with enhanced endogenous protein phosphorylation: effects of retinoic acid. Cell Biol. Internatl. Rept., 4: 1075 – 1079, 1980.CrossRefGoogle Scholar
  37. 37.
    Bunk, M.J., Teland, N.T., Higgins, P.J., Traganos, F., and Sakar, N.H. Effect of N-(4-hydroxyphenyl) retinamide on murine mammary tumor cells in culture. Nutr. Cancer, 7: 105 – 115, 1985.PubMedCrossRefGoogle Scholar
  38. 38.
    Bashor, M.M., Toft, D.O., and Chytil, F. In vitrobinding of retinol to rat tissue compounds. Proc. Natl. Acad. U.S.A., 70: 3483 – 3487, 1973.CrossRefGoogle Scholar
  39. 39.
    Takase, S., Ong., D.E., and Chytil, F. Cellular retinol-binding protein allows specific interaction of retinol with the nucleus in vitro. Proc. Natl. Acad. Sci. U.S.A., 76: 2204 – 2208, 1979.PubMedCrossRefGoogle Scholar
  40. 40.
    Mehta, R.G., Cerny, W.L., and Moon, R.C. Nuclear interactions of retinoic acid-binding protein in chemically induced mammary adenocarcinoma. Biochem. J., 208: 731 – 736, 1982.PubMedGoogle Scholar
  41. 41.
    Ong, D.E., and Chytil, F. Presence of cellular retinol and retinoic-acid binding proteins in experimental tumors. Cancer Letters, 2: 25 – 30, 1976.PubMedCrossRefGoogle Scholar
  42. 42.
    Sani, B.P., and Corbett, T.H. Retinoic-acid binding protein in normal tissues and experimental tumors. Cancer Res., 37: 209 – 213, 1977.Google Scholar
  43. 43.
    Sani, B.P., and Titus, B.C. Retinoic acid-binding protein in experimental tumors and in tissues with metastatic tumor foci. Cancer Res., 37: 4031 – 4034, 1977.PubMedGoogle Scholar
  44. 44.
    Mehta, R.G., Cerny, W.L., and Moon, R.C. Distribution of retinoic acid-binding proteins in normal and neoplastic mammary tissues. Cancer Res., 40: 47 – 49, 1980.PubMedGoogle Scholar
  45. 45.
    Mehta, R.G., McCormick, D.L., Cerny, W.L., and Moon, R.C Correlation between retinoid inhibition of N-methyl-N-nitrosourea-induced mammary carcinogenesis and levels of retinoic acid-binding proteins. Carcinogenesis, 3: 89 – 91, 1982.PubMedCrossRefGoogle Scholar
  46. 46.
    Bunk, M.J., Telang, N.T., and Sarkar, N.H. Effect of malignant transformation upon the cellular retinoid-binding proteins in cultured murine mammary cells. Cancer Letters, 20: 83 – 92, 1983.PubMedCrossRefGoogle Scholar
  47. 47.
    Yuspa, S.H., Elgjo, K., Morse, M.A., and Wiebel, F.J. Retinyl acetate modulation of cell growth and carcinogen-cellular interactions. Chem. Biol. Interact., 16: 251 – 264, 1977.PubMedCrossRefGoogle Scholar
  48. 48.
    Khandiya, K.L., Dogra, S.C., and Sharma, R.R. Body vitamin A status and binding of 7,12-dimethylbenzanthracene to rat mammary gland DNA. Ind. J. Med. Res. 76: 702 – 709, 1982.Google Scholar
  49. 49.
    Genta, V.M., Kaufman, D.G., Harris, C.C., Smith, J.M., Sporn, M.B. and Saffioti, U. Vitamin A deficiency enhances binding of benzopyrene to tracheal epithelial DNA. Nature 247: 48 – 49, 1974.PubMedCrossRefGoogle Scholar
  50. 50.
    McCormick, A.M., Napoli, J.L., Yoshizawa, S. and DeLuca, H.F. 5,6-Epoxyretinoic acid as a physiological metabolite of retinoic acid in the rat. Biochem. J. 186: 475 – 481, 1980.PubMedGoogle Scholar
  51. 51.
    Levine, L. and Ohucki, K. Retinoids as well as tumor promoters enhance deacylation of cellular lipids and prostaglandin production in MDCK cells. Nature 276: 274 – 275, 1978.PubMedCrossRefGoogle Scholar
  52. 52.
    Shoyab, M. Effect of prostaglandins and some anti-inflammatory drugs on the binding of 7,12-dimethylbenzanthracene to DNA of murine epidermal cells in culture. Cancer Letters 7: 155 – 162, 1979.PubMedCrossRefGoogle Scholar
  53. 53.
    Hill, D.L. and Shih, T.W. Vitamin A compounds and analogs as inhibitors of mixed-function oxidases that metabolize carcinogenic polycyclic hydrocarbons and other compounds. Cancer Res. 34: 564 – 570, 1974.PubMedGoogle Scholar
  54. 54.
    Miranda, C.L., Mukhtar, H., Bend, J.R. and Clihabra, R.S. Effects of vitamin A deficiency on hepatic and extrahepatic mixed-function oxidase and epoxide-metabolizing enzymes in guinea pig and rabbit. Biochem. Pharmacol. 28: 2713 – 2716, 1979.PubMedCrossRefGoogle Scholar
  55. 55.
    Narisawa, T., Reddy, B.S., Wong, C.G. and Weisburger, J.H. Effect of vitamin A deficiency on rat colon carcinogenesis by N-methyl-N-nitro-N-nitrosoguanidine. Cancer Res. 36: 1379 – 1383, 1976.PubMedGoogle Scholar
  56. 56.
    Welsch, C.W., Goodrich-Smith, M., Brown, C.K. and Roth, L. The prophylaxis of rat and mouse mammary gland tumorigenesis by suppression of prolactin secretion: a reappraisal. Breast Cancer Research and Treatment 1: 225 – 232, 1981.PubMedCrossRefGoogle Scholar
  57. 57.
    Welsch, C.W., Goodrich-Smith, M., Brown, C.K., Mackie, D. and Johnson, D. 2-Bromo-alpha-ergocryptine (CB-154) and tamoxifen (ICI 46, 474)-induced suppression of the genesis of mammary carcinomas in female rats treated with 7,12-dimethylbenzanthracene (DMBA): a comparison. Oncology 39: 88 – 92, 1982.PubMedCrossRefGoogle Scholar
  58. 58.
    Mehta, R.G. and Moon, R.C. Inhibition of DNA synthesis by retinyl acetate during chemically induced mammary carcinogenesis. Cancer Res. 40: 1109 – 1111, 1980.PubMedGoogle Scholar
  59. 59.
    Fell, H.B. and Dingle, J.T. Studies on the mode of action of excess vitamin A. 6. Lysosomal protease and the degradation of cartilage matrix. Biochem. J. 87: 403 – 408, 1967.Google Scholar
  60. 60.
    Shamberger, R.J. Inhibitory effect of vitamin A on carcinogenesis. J. Natl. Cancer Inst. 47: 667 – 673, 1971.PubMedGoogle Scholar
  61. 61.
    Lotan, R. Effects of vitamin A and its analogues (retinoids) on normal and neoplastic cells. Biochem. Biophys. Acta. 605: 33 – 90, 1980.PubMedGoogle Scholar
  62. 62.
    DeLuca, L.M. The direct involvement of vitamin A in glycosyl transfer reactions in mammalian membranes. Vitamins and Hormones, 35: 1 – 57, 1977.CrossRefGoogle Scholar
  63. 63.
    Warren, L., Buck, C.A. and Tuszynski, G.P. Glycopeptide changes and malignant transformation. A possible role for carbohydrate in malignant behavior. Biochem. Biophys. Acta. 516: 97 – 127, 1978.PubMedGoogle Scholar
  64. 64.
    Betram, J.S., Mordan, L.J., Domanska-Janik, K. and Bernacki, R.J. Inhibition of in vitroneoplastic transformation by retinoids. In:M.S. Arnott, J. Van Eys, and Y.M. Wang (eds.), Molecular Interactions of Nutrition and Cancer, 315–335. New York, Raven Press, 1982.Google Scholar
  65. 65.
    Adams, S., Sasak, W., Dick, L.D., and DeLuca, L.M. Studies on the mechanism of retinoid-induced adhesion of spontaneously transformed mouse fibroblasts. Acta. Vitaminol. Enzymol. 5: 3 – 11, 1983.Google Scholar
  66. 66.
    Zile, M.H. and Cullum, M.E. The function of vitamin A: Current concepts. Proc. Soc. Exptl. Biol. Med. 172: 139 – 152, 1983.Google Scholar
  67. 67.
    Jetten, A.M., Meeks, R.G. and DeLuca, L.M. Specific and nonspecific alterations in membrane microviscosity induced by retinoids in embryonal carcinoma and fibroblast cells. Ann. New York Acad. Sci. 359: 398 – 400, 1981.CrossRefGoogle Scholar
  68. 68.
    Todaro, G.J., DeLarco, J.E. and Sporn, M.B. Retinoids block pheno-typic cell transformation produced by sarcoma growth factor. Nature 276: 272 – 274, 1978.PubMedCrossRefGoogle Scholar
  69. 69.
    Welsch, C.W. and Nagasawa, H. Prolactin and murine mammary tumorigenesis: a review. Cancer Res. 37: 951 – 963, 1977.PubMedGoogle Scholar
  70. 70.
    Welsch, C.W., Iturri, C. and Brennan, M.J. DNA synthesis of human, mouse and rat mammary carcinomas in vitro. Influence of insulin and prolactin. Cancer 38: 1272 – 1281, 1976.PubMedCrossRefGoogle Scholar
  71. 71.
    Mehta, R.G., Cerny, W.L. and Moon, R.C. Retinoids inhibit prolactin induced development of the mammary gland in vitro. Carcinogenesis 4: 23 – 26, 1983.PubMedCrossRefGoogle Scholar
  72. 72.
    Wolbach, S.B. and Howe, P.R. Tissue changes following deprivation of fat soluble vitamin A. J. Exp. Med. 42: 753 – 778, 1925.PubMedCrossRefGoogle Scholar
  73. 73.
    Sankaran, L. and Topper, Y.J. Effect of vitamin A deprivation on maintenance of rat mammary tissue and on the potential of the epithelium for hormone-dependent milk protein synthesis. Endocrinology 111: 1061 – 1067, 1982.PubMedCrossRefGoogle Scholar
  74. 74.
    Speers, W.C. Conversion of malignant murine embryonal carcinomas to benign teratomas by chemical induction of differentiation in vivo. Cancer Res. 42: 1843 – 1849, 1982.PubMedGoogle Scholar
  75. 75.
    Dresser, D.W. Adjuvanticity of vitamin A. Nature 217: 527 – 529, 1968.PubMedCrossRefGoogle Scholar
  76. 76.
    Medawar, P.B. and Hunt, R. Anti-cancer action of retinoids. Immunology, 42: 349 – 353, 1981.PubMedGoogle Scholar
  77. 77.
    Athanassiades, T.J. Adjuvant effect of vitamin A palmitate and analogs on cell-mediated immunity. J. Natl. Cancer Inst. 67: 1153 – 1156, 1981.PubMedGoogle Scholar
  78. 78.
    Rhodes, J. and Oliver, S. Retinoids as regulators of macrophage function. Immunology 40: 467 – 472, 1980.PubMedGoogle Scholar
  79. 79.
    Meltzer, M.S. and Cohen, B.E. Tumor suppression by mycobaterium bovis (strain BCG) enhanced by vitamin A. J. Natl. Cancer Inst. 53: 585 – 587, 1974.PubMedGoogle Scholar
  80. 80.
    Schroder, E.W. and Black, P.H. Guest editorial: Retinoids: tumor preventers or tumor enhancers. J. Natl. Cancer Inst. 65: 671 – 674, 1980.PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1987

Authors and Affiliations

  • Clifford W. Welsch
    • 1
  1. 1.Department of AnatomyMichigan State UniversityEast LansingUSA

Personalised recommendations